Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Giannotti

Showing results (21-30 of 23) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 23 results.
Journal of Thrombosis and Haemostasis : JTH|May 13, 2006
Markers of hypercoagulability and inflammation predict mortality in patients with heart failureR Marcucci, A M Gori, F Giannotti, et al.
Leukemia|January 26, 2017
Outcomes of UCB transplantation are comparable in FLT3+ AML: results of CIBMTR, EUROCORD and EBMT collaborative analysisC Ustun, F Giannotti, M-J Zhang, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|November 13, 2013
High incidence of post-transplant cytomegalovirus reactivations in myeloma patients undergoing autologous stem cell transplantation after treatment with bortezomib-based regimens: a survey from the Rome transplant networkF Marchesi, A Mengarelli, F Giannotti, et al.
Pageof 3

Showing results (21-30 of 23) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 23 results.
Journal of Thrombosis and Haemostasis : JTH|May 13, 2006
Markers of hypercoagulability and inflammation predict mortality in patients with heart failureR Marcucci, A M Gori, F Giannotti, et al.
Leukemia|January 26, 2017
Outcomes of UCB transplantation are comparable in FLT3+ AML: results of CIBMTR, EUROCORD and EBMT collaborative analysisC Ustun, F Giannotti, M-J Zhang, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|November 13, 2013
High incidence of post-transplant cytomegalovirus reactivations in myeloma patients undergoing autologous stem cell transplantation after treatment with bortezomib-based regimens: a survey from the Rome transplant networkF Marchesi, A Mengarelli, F Giannotti, et al.
Pageof 3